Alzheimer’s disease is an illness that has taken hold of the lives of over 3 million Americans. This neurodegenerative disease causes affected individuals to experience a cognitive decline, and a lack of memory retention. The buildup of amyloid- ß protein in neuronal cells is a likely cause of Alzheimer’s. While most research experiments concerning Alzheimer’s disease focus on the more aggressive stages of the illness, the goal of this research was to increase the transport rate of amyloid- ß proteins out of the brain cells using P-glycoprotein. A buffered mixture of P-glycoprotein, ATP, and the fluorescent tag Rhodamine 123 was combined in a cuvette and analyzed by fluorometry. The goal was to find the ideal concentration of these substrat...
Alzheimer’s disease (AD) is a devastating neurodegenerative condition in which accumulation of amylo...
Alzheimer’s Disease (AD) affects over 5.8 million people in the United States each year. This number...
Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized\ud by an extracellular...
Alzheimer’s disease is a neurodegenerative disorder and the most common form of dementia. One of the...
A major pathological hallmark of Alzheimer’s disease is accumulation of amyloid-b in senile plaques ...
The accumulation of amyloid-b (Ab) peptides is a key histopathological feature of the Alzheimer's b...
abstract: As Alzheimer’s disease (AD) increases in incidence, there is an increased investigation in...
La maladie d'Alzheimer est devenue le désordre neurodégénérarif le plus important chez les personnes...
New therapeutic approaches in Alzheimer’s disease are urgently needed. The normal plasma protein, se...
Alzheimer disease is the most common form of dementia, affecting more than 5 million people in the U...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
Alzheimer's disease is the most important cause of dementia but there is no therapy that has been de...
Alzheimer’s Disease, also called AD, is a horrible, degenerative brain disease that more than 35 mil...
Abstract only availableAmyloid-Beta peptide (Aß), a causative agent in Alzheimer's disease (AD), is ...
In our study, we attempted to investigate the influences of P-glycoprotein (P-gp) on DL0410, a novel...
Alzheimer’s disease (AD) is a devastating neurodegenerative condition in which accumulation of amylo...
Alzheimer’s Disease (AD) affects over 5.8 million people in the United States each year. This number...
Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized\ud by an extracellular...
Alzheimer’s disease is a neurodegenerative disorder and the most common form of dementia. One of the...
A major pathological hallmark of Alzheimer’s disease is accumulation of amyloid-b in senile plaques ...
The accumulation of amyloid-b (Ab) peptides is a key histopathological feature of the Alzheimer's b...
abstract: As Alzheimer’s disease (AD) increases in incidence, there is an increased investigation in...
La maladie d'Alzheimer est devenue le désordre neurodégénérarif le plus important chez les personnes...
New therapeutic approaches in Alzheimer’s disease are urgently needed. The normal plasma protein, se...
Alzheimer disease is the most common form of dementia, affecting more than 5 million people in the U...
The Alzheimer's Association estimated this year that every 72 seconds, someone in America develops A...
Alzheimer's disease is the most important cause of dementia but there is no therapy that has been de...
Alzheimer’s Disease, also called AD, is a horrible, degenerative brain disease that more than 35 mil...
Abstract only availableAmyloid-Beta peptide (Aß), a causative agent in Alzheimer's disease (AD), is ...
In our study, we attempted to investigate the influences of P-glycoprotein (P-gp) on DL0410, a novel...
Alzheimer’s disease (AD) is a devastating neurodegenerative condition in which accumulation of amylo...
Alzheimer’s Disease (AD) affects over 5.8 million people in the United States each year. This number...
Alzheimer's disease (AD) is a severe neurodegenerative disorder characterized\ud by an extracellular...